Document Detail


Isoxyl particles for pulmonary delivery: In vitro cytotoxicity and potency.
MedLine Citation:
PMID:  20600722     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary delivery of isoxyl may increase drug efficacy by targeting alveolar macrophages which are host cells for Mycobacteria. Isoxyl microparticles (1-2microm) were obtained by antisolvent precipitation and simultaneous spray drying method. The controls were made by mixing isoxyl solution in DMSO with cell culture media. Depending on the drug concentration, either isoxyl solution or nanosuspension was obtained in these controls. In the study, MTT (methylthiazol tetrazolium) and LDH (lactose dehydrogenase) assays were utilized to test cytotoxicity of these particle suspensions or solutions toward macrophages. Isoxyl microparticles and controls in concentrations up to 100microg/ml were not toxic to macrophages. Both isoxyl microparticle suspensions and controls showed bactericidal activity, as estimated by death of mycobacteria inside the macrophages, at a concentration of 5microg/ml.
Authors:
Chenchen Wang; Anthony J Hickey
Publication Detail:
Type:  Journal Article     Date:  2010-06-25
Journal Detail:
Title:  International journal of pharmaceutics     Volume:  396     ISSN:  1873-3476     ISO Abbreviation:  Int J Pharm     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-26     Completed Date:  2010-11-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7804127     Medline TA:  Int J Pharm     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  99-104     Citation Subset:  IM    
Copyright Information:
Copyright 2010. Published by Elsevier B.V.
Affiliation:
Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Division of Molecular Pharmaceutics, Campus Box #7571, 1310 Kerr Hall, Chapel Hill, NC 27599, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Antitubercular Agents / administration & dosage,  chemistry,  pharmacology*,  toxicity
Cell Line
Cell Survival / drug effects
Chemical Precipitation
Chemistry, Pharmaceutical
Colony Count, Microbial
Dimethyl Sulfoxide / chemistry
Dose-Response Relationship, Drug
Drug Compounding
Humans
Macrophages / drug effects,  microbiology*,  pathology
Microbial Sensitivity Tests
Mycobacterium bovis / drug effects*,  growth & development
Nanoparticles
Particle Size
Phenylthiourea / administration & dosage,  analogs & derivatives*,  chemistry,  pharmacology,  toxicity
Powders
Solvents / chemistry
Technology, Pharmaceutical / methods
Chemical
Reg. No./Substance:
0/Antitubercular Agents; 0/Powders; 0/Solvents; 103-85-5/Phenylthiourea; 67-68-5/Dimethyl Sulfoxide; 910-86-1/thiocarlide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of a P-glycoprotein modulator on the pharmacokinetics and distribution of free levobupivacai...
Next Document:  Antitumor effects of guanosine-analog phosphonates identified by molecular modelling.